Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.240
+0.030 (2.48%)
At close: Aug 19, 2026, 4:00 PM EDT
1.250
+0.010 (0.81%)
After-hours: Aug 19, 2026, 5:47 PM EDT
Metagenomi Therapeutics Employees
Metagenomi Therapeutics had 113 employees as of June 30, 2026. The number of employees decreased by 58 or -33.92% compared to the same quarter last year.
Employees
113
Change
-58
Growth
-33.92%
Revenue / Employee
$120,009
Profits / Employee
-$827,097
Market Cap
46.84M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 113 | -58 | -33.92% |
| Mar 31, 2026 | 118 | -58 | -32.95% |
| Dec 31, 2025 | 119 | -83 | -41.09% |
| Sep 30, 2025 | 124 | -83 | -40.10% |
| Jun 30, 2025 | 171 | -57 | -25.00% |
| Mar 31, 2025 | 176 | -61 | -25.74% |
| Dec 31, 2024 | 202 | -34 | -14.41% |
| Sep 30, 2024 | 207 | -16 | -7.17% |
| Jun 30, 2024 | 228 | 28 | 14.00% |
| Mar 31, 2024 | 237 | 37 | 18.50% |
| Dec 31, 2023 | 236 | - | - |
| Sep 30, 2023 | 223 | - | - |
| Jun 30, 2023 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Alps Group | 93 |
| Aligos Therapeutics | 82 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| Veru Inc. | 20 |
| Instil Bio | 17 |
| Context Therapeutics | 15 |
MGX News
- 8 days ago - Metagenomi price target lowered to $7 from $9 at Wells Fargo - TheFly
- 9 days ago - Metagenomi Therapeutics Quarterly report: Q2 2026 - Filings
- 9 days ago - Metagenomi Therapeutics Earnings release: Q2 2026 - Filings
- 5 weeks ago - Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio - GlobeNewsWire
- 6 weeks ago - Metagenomi transferred with a Buy at Chardan - TheFly
- 2 months ago - Metagenomi Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 2 months ago - Metagenomi Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts